MuReva is a medical device innovator with a mission to treat Oral Mucositis, a debilitating side effect of cancer treatment. Our patented device utilizing photobiomodulation can treat and potentially prevent this terrible side effect that impacts over 3 million patients every year. Our first clinical trials are in head and neck cancer patients undergoing radiation and concurrent chemotherapy. Our aspiration is to help reduce mucosal injury in patients undergoing radiation and chemotherapy for various cancers.
Website: https://murevapt.com